Paramax Comp 500 mg / 30 mg Norge - norsk - Statens legemiddelverk

paramax comp 500 mg / 30 mg

vitabalans oy - paracetamol / kodeinfosfathemihydrat - tablett - 500 mg / 30 mg

Trimonil Retard 300 mg Norge - norsk - Statens legemiddelverk

trimonil retard 300 mg

desitin arzneimittel gmbh - karbamazepin - depottablett - 300 mg

Trimonil Retard 150 mg Norge - norsk - Statens legemiddelverk

trimonil retard 150 mg

desitin arzneimittel gmbh - karbamazepin - depottablett - 150 mg

Trimonil Retard 600 mg Norge - norsk - Statens legemiddelverk

trimonil retard 600 mg

desitin arzneimittel gmbh - karbamazepin - depottablett - 600 mg

Trimonil Retard 300 mg Norge - norsk - Statens legemiddelverk

trimonil retard 300 mg

orifarm as - karbamazepin - depottablett - 300 mg

Trimonil Retard 300 mg Norge - norsk - Statens legemiddelverk

trimonil retard 300 mg

orifarm as - karbamazepin - depottablett - 300 mg

Paracetamol Norfri 500 mg Norge - norsk - Statens legemiddelverk

paracetamol norfri 500 mg

evolan pharma ab - paracetamol - brusetablett - 500 mg

Paracetamol Norfri 500 mg Norge - norsk - Statens legemiddelverk

paracetamol norfri 500 mg

evolan pharma ab - paracetamol - tablett, filmdrasjert - 500 mg

Paracetamol Baxter 10 mg/ ml Norge - norsk - Statens legemiddelverk

paracetamol baxter 10 mg/ ml

baxter holding b.v. - paracetamol - infusjonsvæske, oppløsning - 10 mg/ ml

Mounjaro Den europeiske union - norsk - EMA (European Medicines Agency)

mounjaro

eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - legemidler som brukes i diabetes - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 og 5.